IP Library Granted Patent US 11,085,919
Granted Patent B2
US 11,085,919 · App. 16/151,516 · Granted Aug 10, 2021

Method for detecting chemical substances in samples of material that can be taken from a subject, in particular for detecting embryotoxic factors

Inventors: Massimiliano Manganini (Mozzate, IT); Renato Colognato (Ispra, IT); Massimo Mariotti (Legnano, IT); Alessandro Scozzesi (San Zeno Naviglio, IT)
Assignee: INNOVITAS VITAE S.R.L.
G01N33/5088G01N33/5091G01N33/689G01N2800/368
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,085,919
App. No.
16/151,516
Granted
Aug 10, 2021
Kind
B2
Abstract

A method for detecting chemical substances in samples of material that can be taken from a subject, comprising a step of preparing a sample of a substance coming from a donor organism; a step of associating with said sample of a substance a control element suitable for verifying a presence of at least one active agent in the sample of the substance and a step of verifying the presence or absence of the active agent based on a change in state in said control element; the control element comprising at least one living organism having the ability to nourish itself autonomously through temporary organs associated with the living organism itself and able to supply nutritive substances to the latter without taking said nutritive substances from an outside environment.

Claims (26)

1. A method for suppressing an immune system of a donor subject in which embryotoxic factors (ETFs) are present comprising the following steps:

preparing a sample of blood serum and/or plasma from the donor subject;

associating, with the sample, a control element suitable for verifying a level of the ETFs in the sample;

verifying the level of the ETFs in the sample based on a level of change of state of the control element, the verifying comprising the following sub-steps:

maintaining an environmental interaction between the control element and the sample for a defined period; and

attributing to the sample a toxicity level based on the level of change of state of the control element, the toxicity level being proportional and quantitatively correlated to a quantitative level of the ETFs in the sample; and

exposing the donor subject to immune-system suppressing agents based on the level of change of state of the control element,

wherein:

the control element comprises one or more living organisms comprising at least one fish belonging to the class Actinopterygii , having the ability to nourish itself autonomously through one or more temporary organs associated with the living organism, and being able to supply nutritive substances to the one or more temporary organs without taking the nutritive substances from an outside environment; and

the donor subject is a human or an animal.

2. The method according to claim 1 , wherein the at least one fish is of the species Danio rerio.

3. The method according to claim 2 , wherein the at least one fish of the species Danio rerio belongs to a strain of genotype “AB”.

4. The method according to claim 1 , wherein the one or more temporary organs comprise yolk sac temporary organs that are developed integrally with the one or more living organisms.

5. The method according to claim 1 , wherein the step of associating the control element with the sample comprises the following sub-steps:

exposing a predetermined number of the one or more living organisms to the sample, the predetermined number preferably being at least 20 embryos of Danio rerio having a development and/or cell multiplication time no greater than 72 hours after fertilization;

placing groups of equal numbers of the embryos of Danio rerio in respective verification containers; and

adding the sample to the verification containers.

6. The method according to claim 5 , wherein the verification containers comprise at least two adjacent wells of a culture plate.

7. The method according to claim 5 , wherein:

the sub-step of maintaining an environmental interaction between the control element and the sample is carried out in the verification containers, the defined period ranging from 12 hours to 48 hours; and

the sub-step of attributing to the sample a toxicity level is carried out by counting a number of deceased embryos after the defined period and attributing to the sample a toxicity level based on the number of deceased embryos.

8. The method according to claim 7 , wherein the toxicity level is defined as “toxic” when the number of dead embryos exceeds 50% of the total number of embryos placed in the verification containers, the toxicity level being alternatively defined as “moderately toxic” when the number of dead embryos ranges between 50% and 30% of the total number of embryos placed in the verification containers, and the toxicity level being alternatively defined as “non-toxic” when the number of dead embryos is less than or equal to 20% of the total number of embryos placed in the verification containers.

9. The method according to claim 1 , wherein the step of exposing the donor subject to the immune-system suppressing agents comprises administering infusions of immunoglobulin and/or suppressors of cytokine production.

10. The method according to claim 9 , wherein the infusions are administered intravenously.

11. The method according to claim 1 , wherein the step of exposing the donor subject to the immune-system suppressing agents comprises applying progesterone and/or progesterone oil topically on the donor subject or to a culture medium suitable for artificial insemination processes associated with the donor subject.

12. The method according to claim 1 , wherein the step of exposing the donor subject to the immune-system suppressing agents comprises administering one or more of vitamin, non-vitamin, or nutraceutic compounds, natural or phytotherapeutic active ingredients, or food supplements.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2025
From: INNOVITAS VITAE SRL IN LIQUIDAZIONE
To: CAPOFERRI FAMILY S.R.L.
Reel/Frame 071357/0364 →
CHANGE OF NAME Recorded Jun 9, 2025
From: INNOVITAS VITAE SRL
To: INNOVITAS VITAE SRL IN LIQUIDAZIONE
Reel/Frame 071610/0822 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: GEXNANO S.R.L.
To: INNOVITAS VITAE S.R.L.
Reel/Frame 050785/0830 →
CHANGE OF ADDRESS Recorded Oct 22, 2019
From: INNOVITAS VITAE S.R.L.
To: INNOVITAS VITAE S.R.L.
Reel/Frame 051350/0868 →
Priority Claims (1)
IT MI2013A000916 · Jun 4, 2013 · national
Continuity (2)
Continuation 14895416
Related Publication 20190033298A1 · Jan 31, 2019